We demonstrated that reserpine, a discontinued blood pressure medication, suppressed EV incorporation and prevented cancer cell EV-mediated cancer progression by suppressing the loss of IFNAR1 and CH25H[13]. The gene discussed is IFNAR1; the disease is cancer.